COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available

Brasil Notícia Notícia

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 71%

COVID-19 cases, hospitalizations, and fatalities prevented by SARS-CoV-2 vaccination within the first 6 months after the vaccine became available medrxivpreprint Columbia ColumbiaMSPH COVID19 coronavirus covid vaccination vaccine SARSCoV2

By Bhavana KunkalikarSep 28 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 vaccination in the US.

The team combined a data assimilation technique with a metapopulation model coupled with a Susceptible-Exposed-Infected-Recovered structure. Here, the spread of SARS-CoV-2 throughout and among the 3142 American counties was simulated. The reported case counts for each American county from the time the first COVID-19 cases were discovered there in February 2020 through the date of the first authorized SARS-CoV-2 vaccination on December 14th, 2020, were assessed using the model-inference system.

Related StoriesThe team used data from the US-based Premier Healthcare COVID-19 claims database to multiply the distribution of estimated COVID-19-related hospitalizations prevented by the distribution of expenses per hospitalization episode. The baseline model predicted a total of 16.1 million COVID-19 cases, 1.4 million related hospitalizations, and over 246 thousand deaths between December 14th and June 3rd, 2021. Almost 51% of Americans had received a minimum of one COVID-19 vaccine dose by June 4th, 2021. Location-specific vaccination rates varied greatly, from 35% in Mississippi to 74% in Vermont.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NewsMedical /  🏆 19. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Study investigates long-range RNA-RNA interactions of SARS-CoV-2Study investigates long-range RNA-RNA interactions of SARS-CoV-2Researchers explored RRIs [long-range ribonucleic acid (RNA)-RNA interactions] in SARS-CoV-2 variants of concern genomes to assess evolutionary changes in SARS-CoV-2.
Consulte Mais informação »

What are the neuropsychiatric effects of SARS-CoV-2 infection?What are the neuropsychiatric effects of SARS-CoV-2 infection?What are the neuropsychiatric effects of SARS-CoV-2 infection? medrxivpreprint UMmedschool neuropsychiatric neurology neuroscience psychiatry infection COVID19 coronavirus covid SARSCoV2
Consulte Mais informação »

Systemic inflammation triggered by SARS-CoV-2 found to cause human testicular injurySystemic inflammation triggered by SARS-CoV-2 found to cause human testicular injuryIn a new study, a team of researchers demonstrated that testicular injury in humans is not due to direct SARS-CoV-2 infection but more likely is an indirect effect of exposure to systemic inflammation or SARS-CoV-2 antigens.
Consulte Mais informação »

Study characterizes immunological signature of SARS-CoV-2 infection in childrenStudy characterizes immunological signature of SARS-CoV-2 infection in childrenA recent study has demonstrated that the clinical severity of COVID-19 in children depends on the dynamics of immune response induced by SARS-CoV-2 infection.
Consulte Mais informação »

Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells modelsRational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells modelsIn a recent study posted to the bioRxiv* preprint server, researchers in Australia explored the molecular mechanisms of the pulmonary and cardiac complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using human stem-cell-derived cardiac and lung cells.
Consulte Mais informação »

Observing SARS-CoV-2 Omicron reinfections with different sub-variantsObserving SARS-CoV-2 Omicron reinfections with different sub-variantsObserving SARS-CoV-2 Omicron reinfections with different sub-variants SARSCoV2 COVID19 Omicron Reinfection CDCgov
Consulte Mais informação »



Render Time: 2025-03-01 06:28:57